(Q35603923)

9 August 2017

1 reference

title

ADMA: a novel risk factor that explains excess cardiovascular event rate in patients with end-stage renal disease (English)

1 reference

9 August 2017

0 references

1 reference

Carmine Zoccali

2

0 references

author name string

Rainer H Böger

series ordinal

1

1 reference

9 August 2017

publication date

1 December 2003

1 reference

Atherosclerosis. Supplements

9 August 2017

published in

1 reference

9 August 2017

volume

4

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

23-28

1 reference

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900030-8

7 January 2021

LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900030-8

7 January 2021

Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900030-8

7 January 2021

Dimethylarginines in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900030-8

7 January 2021

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900030-8

7 January 2021

Importance of asymmetrical dimethylarginine in cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900030-8

7 January 2021

Controlling the epidemic of cardiovascular disease in chronic renal disease: where do we start?

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900030-8

7 January 2021

Cardiovascular risk in uraemic patients-is it fully explained by classical risk factors?

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900030-8

7 January 2021

Physiology and biochemistry of endothelial function in children with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900030-8

7 January 2021

Hemodialysis and L-arginine, but not D-arginine, correct renal failure-associated endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900030-8

7 January 2021

The role of carotid arterial intima-media thickness in predicting clinical coronary events

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900030-8

7 January 2021

Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900030-8

7 January 2021

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900030-8

7 January 2021

Asymmetric dimethylarginine increases mononuclear cell adhesiveness in hypercholesterolemic humans

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900030-8

7 January 2021

Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900030-8

7 January 2021

Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900030-8

7 January 2021

Restoring vascular nitric oxide formation by l-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900030-8

7 January 2021

Endogenous nitric oxide synthase inhibitors are responsible for the L -arginine paradox

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2803%2900030-8

7 January 2021

10.1016/S1567-5688(03)00030-8

Identifiers

DOI

1 reference

9 August 2017

1 reference